Showing 3941 - 3950 of 4091 for "Life sciences IP" with applied filters
Filters:
22 August 2019 by Kingsley Egbuonu
The international law firm announced today that its partners have voted to approve a landmark combination with a South Korea law firm – a deal that further expands its presence across the world
20 August 2019 by Kingsley Egbuonu
The law firm recently advised the investment company on two technology transactions, including its investment in the British software company Advanced
19 August 2019 by Kingsley Egbuonu
Five law firms were involved in this multi-billion dollar transaction in the entertainment and media sector
17 August 2019 by Chris Adams and Kingsley Egbuonu
The firm hired four IP litigators, two of whom are ranked as patent stars, from a rival
16 August 2019 by Chris Adams and Kingsley Egbuonu
In a highly-anticipated biologic patent dispute, the US District Court for the District of New Jersey has found that Amgen's patents for Enbrel® (etanercept) are valid. Two ranked firms are involved in this dispute
15 August 2019 by Kingsley Egbuonu
The firm welcomed five new senior IP practitioners this month
14 August 2019 by Kingsley Egbuonu
The firm has hired another transactional lawyer to further strengthen its technology and life sciences practice
13 August 2019 by Kingsley Egbuonu
The firms advised on a transaction involving the acquisition of a biotech company valued at $1 billion
12 August 2019 by Margaret Arnott, Harry Rowe and Daniel Ramos
Margaret Arnott, Harry Rowe and Daniel Ramos of Mathys & Squire analyse the UK’s no-deal Brexit plans for EU trade mark and design rights
09 August 2019 by Kingsley Egbuonu
King & Wood Mallesons (KWM) and Allens involved in the sale of Arnott’s Biscuits
